tiprankstipranks
Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
PremiumThe FlyMolson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
15d ago
Immunome initiated with an Overweight at Stephens
Premium
The Fly
Immunome initiated with an Overweight at Stephens
15d ago
Immunome initiated with an Overweight at Stephens on ‘seasoned leadership’
Premium
The Fly
Immunome initiated with an Overweight at Stephens on ‘seasoned leadership’
15d ago
Immunome price target lowered to $23 from $27 at Piper Sandler
PremiumThe FlyImmunome price target lowered to $23 from $27 at Piper Sandler
3M ago
IMNM Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
IMNM Upcoming Earnings Report: What to Expect?
3M ago
Immunome reports Q2 EPS (60c), consensus (39c)
Premium
The Fly
Immunome reports Q2 EPS (60c), consensus (39c)
3M ago
Immunome promotes Max Rosett to CFO
PremiumThe FlyImmunome promotes Max Rosett to CFO
6M ago
Wedbush sees recent pullback in Immunome share price as buying opportunity
Premium
The Fly
Wedbush sees recent pullback in Immunome share price as buying opportunity
6M ago
Immunome reports Q1 EPS ($2.51), consensus (69c)
Premium
The Fly
Immunome reports Q1 EPS ($2.51), consensus (69c)
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100